Home > Cashflow Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Cash Flow from Operating Activities

    Back to Cashflow Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Cash Flow from Operating Activities ₹23 Cr₹-5.96 Cr₹11 Cr₹16 Cr₹14 Cr

What is the latest Cash Flow from Operating Activities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Cash Flow from Operating Activities ratio of SYNCOM FORMULATIONS (INDIA) is ₹23 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹23 Cr
Mar2024₹-5.96 Cr
Mar2023₹11 Cr
Mar2022₹16 Cr
Mar2017₹14 Cr

How is Cash Flow from Operating Activities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹23 Cr
Positive
Mar2024 ₹-5.96 Cr
Negative
Mar2023 ₹11 Cr
-35.52
Mar2022 ₹16 Cr
17.98
Mar2017 ₹14 Cr -

Compare Cash Flow from Operating Activities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,135.5 Cr 1.9% -14.9% -27.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,000.0 Cr -0.4% 5.3% 13.4% Stock Analytics
DIVIS LABORATORIES ₹161,076.0 Cr -4.3% -6.3% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,510.0 Cr 0.4% 8.2% 44.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,921.0 Cr 0.5% 1.8% 16.4% Stock Analytics
CIPLA ₹106,150.0 Cr -0.8% -2.6% -9.2% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

1.9%

-14.9%

-27.7%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses